Atlas Trials

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Clinical trial NCT01499121 · COMPLETED

Trial details

NCT number
NCT01499121
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Clear Cell, Metastatic Renal Cell Carcinoma
Start date
2012-05-01
Primary completion
2017-09-30
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.